Upregulation of anti-human ribosomal protein S6-p240, topoisomerase II ά, cyclin D1, Bcl-2 and anti-corneal antibodies in acute psoriasis
Background. The immunopathogenesis of psoriasis is complex, and involves alterations in the innate immunologic system Case Report: A 57-year-old female was evaluated for the presence of rapidly appearing plaques on the knees and elbows. Methods: Skin biopsies for hematoxylin and eosin examination, a...
Saved in:
Main Authors: | Howard William R. (Author), Abreu Velez Ana Maria (Author), Howard Michael S. (Author) |
---|---|
Format: | Book |
Published: |
Our Dermatology Online,
2011-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
comment to the article: Upregulation of anti-human ribosomal protein S6-p240, topoisomerase II ά, cyclin D1, Bcl-2 and anti-corneal antibodies in acute psoriasis
by: Norito Ishii, et al.
Published: (2011) -
IgD, cyclooxygenase-2 and ribosomal protein S6-PS240 immune response in a case of early psoriasis
by: Ana Maria Abreu Velez, et al.
Published: (2018) -
Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
by: Prasanna Anjaneyulu Yakkala, et al.
Published: (2023) -
The Potential of Topoisomerase Inhibitor-Based Antibody-Drug Conjugates
by: Seungmin Han, et al.
Published: (2022) -
Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
by: Haugh IM, et al.
Published: (2018)